An employee shows a pack of the Russia's Covid-19 vaccine Convasel at the production laboratory of the St. Petersburg Research Institute of Vaccines and Sera of the Russian Federal Medical and Biological Agency (FMBA), in St. Petersburg, Russia. On March 18, the Russian Health Ministry registered the Convasel vaccine. It was developed by the St. Petersburg Research Institute of Vaccines and Sera. The vaccine is a new generation drug that is aimed at generating cellular immunity. The main mechanisms of the effect of the Convasel vaccine are the production of a specific cellular immune response, a central memory cell phenotype, and the development of an intracellular viral neutralizing response.
- Categories: Science & Technology, Economy, Business & Finance, Health
- Location: St. Petersburg, Russia
- Event date: 11.04.2022
- Date published: 11.04.2022
- Author: Alexander Galperin
- Credit: Sputnik
- Source: Sputnik
- Original: Digital
- Media: JPEG, 5568x3712px, 12.8Mb
- Job-ID: a10af2570e59b65a